60 Day FNR Published

sroberts on DSK5SPTVN1PROD with NOTICES

Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices
Sciences and Epidemiology: Member Conflict
Applications.
Date: March 4–5, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
MSC 7770, Bethesda, MD 20892, 301–254–
9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;Population
Sciences and Epidemiology: Member Conflict
Applications
Date: March 4–5, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
MSC 7770, Bethesda, MD 20892, 301–254–
9975, helmersk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–10–
244: The Collaborative Genetic Study of
Nicotine Dependence.
Date: March 5–6, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting)
Contact Person: Eugene Carstea, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 408–
9756, carsteae@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Development of Appropriate Pediatric
Formulations and Pediatric Drug Delivery
System.
Date: March 5, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Robert C Elliott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: NanoImaging Center.
Date: March 5–7, 2013.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.

VerDate Mar<15>2010

17:23 Feb 07, 2013

Jkt 229001

Contact Person: Joseph Thomas Peterson,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9694, petersonjt@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846- 93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 4, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–02840 Filed 2–7–13; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
Agency Information Collection
Activities: Request for Expressions of
Interest (EOI) To Perform a Chemical
Defense Demonstration Project
Office of Health Affairs
Chemical Defense Program, DHS.
ACTION: 60-Day Notice and request for
comments; New Collection, 1601—
NEW.
AGENCY:

The Department of Homeland
Security, Office of Health Affairs
Chemical Defense Program, will submit
the following Information Collection
Request (ICR) to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995 (Pub. L. 104–13, 44 U.S.C. Chapter
35).
DATES: Comments are encouraged and
will be accepted until April 9, 2013.
This process is conducted in accordance
with 5 CFR 1320.1.
ADDRESSES: Written comments and
questions about this Information
Collection Request should be forwarded
to Office of Health Affairs Chemical
Defense Program, DHS, Attn.: CAPT
Joselito Ignacio,
joselito.ignacio@hq.dhs.gov, 202–254–
5738.
SUMMARY:

The
Chemical Defense Program seeks to
obtain information from respondents
interested in hosting a demonstration
project aimed at developing a
comprehensive chemical defense
framework. The authority for the
Chemical Defense Program to collect
this information can be found in Public
Law 112–74, Consolidated
Appropriations Act, 2012 and
Conference Report 112–331.

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00049

Fmt 4703

Sfmt 9990

9405

The information requested on the
form includes: name of state, local,
tribal, or territorial government agency;
address; submitter’s name, position and
contact information; identified venue
for demonstration project; interest in
developing a chemical defense
capability; specific reasons for the
communities interest and needs for a
chemical defense capability; community
chemical threat assessed risks if
applicable; any additional information
respondent requests for consideration.
As identified in Public Law 112–74 and
Conference Report 112–331, the
Chemical Defense Program must
competitively select the locations for
conducting the chemical defense
demonstration projects. The Chemical
Defense Program will use the provided
information for the selection process.
The Office of Management and Budget
is particularly interested in comments
which:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
Analysis
Agency: Office of Health Affairs
Chemical Defense Program, DHS.
Title: Request for Expressions of
Interest (EOI) To Perform a Chemical
Defense Demonstration Project.
OMB Number: 1601–NEW.
Frequency: Once.
Affected Public: State, Local, or Tribal
Government.
Number of Respondents: 25.
Estimated Time Per Respondent: 20
hours.
Total Burden Hours: 500 Hours.
Dated: January 29, 2013.
Richard Spires,
Chief Information Officer.
[FR Doc. 2013–02886 Filed 2–7–13; 8:45 am]
BILLING CODE 9110–9B–P

E:\FR\FM\08FEN1.SGM

08FEN1